NIH-funded research NIH-funded research

Center developing brain-based treatments for alcohol use and addiction

Official title: Center for the Translational Neuroscience of Alcoholism

Funded at Yale University · NIH-11127631 · Data updated 2026-11-12

This project is trying a medication that targets the brain receptor mGluR5 to reduce heavy drinking and fix brain-circuit problems linked to alcoholism.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionYale University
NIH-funded
Lab location1 site (New Haven, United States)
Project startJune 4, 2001
Project endMay 31, 2026
Funding year2025
Award (this year)$1,737,573
NIH project number5P50AA012870-25
Project IDNIH-11127631 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are adults who drink heavily or have alcohol use disorder and who meet safety criteria for taking experimental brain-active medication and undergoing brain imaging.

Less likely to help

Light drinkers, people not seeking treatment, pregnant individuals, or anyone unable to take experimental brain drugs or undergo scans are unlikely to benefit from participation.

What this research studies

You would hear about work that combines brain imaging, genetics, molecular neuroscience, and medication testing to find better treatments for heavy drinking. The center studies drugs that block mGluR5 in animals to see if they normalize glutamate signaling and reduce both goal-directed and habitual drinking. It also carries out studies in heavy-drinking people that use brain scans and medication to measure drinking and brain changes. The center funds pilot projects to bring new ideas forward and coordinates teams to move promising findings toward clinical use.

Why it matters

Potential benefit: If successful, this work could lead to a new kind of medication that reduces heavy drinking by correcting brain-circuit dysfunction.

How similar studies have gone: Similar approaches with mGluR5 blockers have shown promising results in animals, but human testing of this mechanism is still limited.

Where this research is happening

  • Yale University
    New Haven, United States
    Active

Researchers

  • Principal investigator: Krystal, John H. — Yale University
  • Study coordinator: Krystal, John H.

Related research

Other NIH-funded projects on the same topics.

  • How a brain receptor links heavy drinking and depression

    This work tests whether blocking a brain receptor called NK1R can reduce stress-driven heavy drinking and depressive symptoms in people with both alcohol problems and depression.

    NIH research University of Georgia · Athens, United States · NIH-11400454

  • Genes, brains, and life: understanding alcoholism through family-based genetics

    A large study of families explores how genes, brain biology, and life experiences interact to shape alcohol use, recovery, and relapse across the lifespan.

    NIH research Suny Downstate Medical Center · Brooklyn, United States · NIH-11398201

  • How the brain's immune system affects alcoholism

    This project looks at how brain immune and inflammation systems contribute to heavy drinking and aims to find new treatment targets for people with alcohol use disorder.

    NIH research University of Texas at Austin · Austin, United States · NIH-11306624

  • Testing new medications for alcohol dependence and related pain issues.

    This study is looking at new medications that might help people dealing with alcohol dependence and the emotional and pain issues that often come with it, so that one day, there could be better treatment options for those who need them.

    NIH research Lsu Health Sciences Center · New Orleans, United States · NIH-11218407

  • Family genetics of alcohol use disorder

    This project looks at how genes, brain function, and life circumstances shape alcohol problems, recovery, and relapse in people from large families, with a new focus on those aged 40 and older.

    NIH research Suny Downstate Medical Center · Brooklyn, United States · NIH-11195688

  • Mavoglurant's effects on brain reward and impulsivity in people with inherited risk for alcoholism

    This project gives mavoglurant and uses brain scans during reward and impulse-control tasks to see differences between people with and without a family history of alcoholism.

    NIH research Yale University · New Haven, United States · NIH-11127634

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.